Similarly, the expected ratios of ApoE ε4 carriers are strongly reduced compared to patients not carrying the allele (Figure 6(d) and Supplemental Figures S6(d), confirming the important role of this genetic risk factor in AD progression). Here, APOE is linked to Alzheimer disease.